FDA Drug Application (202402) for IBUPROFEN LYSINE by EXELA PHARMA SCIENCE

Back to FDA Applications sponsored by EXELA PHARMA SCIENCE

Application Number202402
Product Number001
FormINJECTABLE;INTRAVENOUS
DosageEQ 20MG BASE/2ML (EQ 10MG BASE/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameIBUPROFEN LYSINE
Active IngredientIBUPROFEN LYSINE

Active IngredientCount
List of drugs with Active Ingredient IBUPROFEN LYSINE2


Back to FDA Applications sponsored by EXELA PHARMA SCIENCE